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Abstract 
The unicellular eukaryotic organism Saccharomyces cerevisiae (budding yeast) is routinely 
used for production of high-value chemical compounds in the biotechnology industry. To 
improve production yields, it is fundamental to understand cellular metabolism, i.e. all 
biochemical reactions that occur inside the cell. In the past 20 years, genome-scale metabolic 
models (GEMs) have risen as computational tools for simulating all possible metabolic 
phenotypes that the cell can attain, while respecting constraints such as mass balances and 
reaction reversibilities. However, the number of metabolic states bound to only those 
constraints is infinite; therefore, it becomes necessary to include additional condition-
specific constraints. Moreover, we would like these constraints to reflect physical limitations 
inside the cell, avoiding arbitrary ad-hoc bounds. 
 
In this thesis, approaches for including abundance constraints (i.e. constraints based on 
absolute abundances of different biomolecules) are evaluated in a GEM of S. cerevisiae. 
First, the GEM approach and how it has been used in S. cerevisiae is reviewed, identifying 
key areas for development. Afterwards, the concepts of sustainable model development and 
multi-layer experimental data generation are presented as foundation stones for constructing 
integrative analysis. Regarding the first concept, a systematic way of recording changes in a 
GEM using a version-controlled system is introduced, allowing reproducibility and open 
collaboration from the community. Regarding the second concept, a multi-omics dataset of 
yeast grown under different temperature, osmotic and ethanol stresses is presented and used 
throughout the thesis for studying metabolism. 
 
The major part of this work focuses on the integration into GEMs of abundance data of two 
types of bio-molecules: lipids and enzymes. First, a method for integrating lipid 
requirements in an unbiased way (SLIMEr) is presented and implemented for yeast, to show 
that lipid metabolism can be re-arranged without spending high amounts of energy. 
Secondly, a method for adding so-called “enzyme constraints” into a GEM (GECKO) is 
developed. These enzyme constraints limit reaction rates by the absolute abundance of 
enzymes, and prove to be crucial for explaining yeast physiology and computing enzyme 
usage in metabolism. Thirdly, the quantification technique used for estimating enzyme 
abundances is analyzed in terms of accuracy and precision, and further improved by varying 
the normalization and scaling steps. Finally, GECKO is used on the stress dataset to create 
enzyme-constrained models of yeast representing each stress condition. This allows 
comparing the distribution of enzyme usage within and between conditions, highlighting 
enzymes that play an important role in the metabolic response to stress. 
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1. Background 
 
 
Biotechnology, the exploitation of biological processes for the benefit of humanity, has 
become one of the main industries in our current economy [2]. A big part of biotechnology 
relies on studying microorganisms, and how to tune them to best suit the corresponding 
application. Metabolism, the interplay of chemical reactions inside microorganisms, is a key 
layer for understanding microorganisms’ responses and for using them to our advantage. In 
this chapter I introduce yeast metabolism (my subject of study in this thesis), go through 
Paper I, which reviews metabolic modeling in yeast, and introduce the aim and significance 
of this thesis. 
 
 
1.1. Saccharomyces cerevisiae 
 
Saccharomyces cerevisiae, also referred to as baker’s yeast or budding yeast, was most likely 
the first microorganism ever used for a biotechnology application: alcoholic fermentation 
[3]. Until today, it is one of the most utilized organisms in industrial biotechnology [4], with 
applications ranging from bread, beer and wine making, to production of biofuels, food 
additives and pharmaceuticals [5]. Note that in this thesis, the word “yeast” will be often 
used to refer to S. cerevisiae, with apologies to other yeast species [6]. 
 
S. cerevisiae has two important properties that makes it an interesting subject of research: 
ease of growth and high complexity. On one hand, it is a unicellular organism that grows 
fast in laboratory conditions, which eases the generation of data compared to e.g. plant or 
human cells. However, unlike other fast-growing organisms such as Escherichia coli and 
Bacillus subtilis, it is eukaryal, meaning among others that cellular functions are 
compartmentalized into several organelles (nucleus, mitochondria, etc.) just like higher 
organisms such as human cells. Therefore, S. cerevisiae can also be used as a model 
organism for studying complex biomolecular processes, such as human diseases [7]. In 
summary, budding yeast is of high value both for the industrial and research communities; 
therefore, a better understanding of its inner workings would yield economic benefits and 
fundamental insight into the biological process of life. 
 
 
1.2. Cellular metabolism 
 
Metabolism, the process of generating energy and components for growth, is arguably the 
most important cellular process [8]; without it the cell would not be able to generate energy 
to perform any other basic task required for life, such as reproduction or homeostasis. 
Metabolism consists of thousands of different chemical reactions, which, for simplicity, are 
1.2. Cellular metabolism 
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classified into different metabolic pathways. These reactions convert nutrients into 
thousands of different intermediate chemical compounds, referred to as metabolites, some 
which are needed for growth and reproduction, and some which are excreted as by-products 
(Figure 1). As most cellular reactions would either not occur spontaneously due to their 
thermodynamic properties, or would be too slow to support life in a competitive environment 
with limited resources, cells express enzymes, a type of protein which can catalyze reactions, 
i.e. accelerate their rate. Different enzymes are specific to different metabolic reactions, and 
the required information to express them is encoded in the cell’s DNA.  
 
 
 
 
Figure 1: A simple diagram of metabolism. 
 
 
Metabolism can broadly be classified into catabolism and anabolism [9]. Catabolism 
includes all metabolic reactions that break down metabolites to generate energy, most often 
in the form of adenosine triphosphate (ATP). Anabolism in turn includes reactions that build 
up biomolecules that form the main components of the cell: proteins, RNA, DNA, 
carbohydrates and lipids. The first four mentioned components are polymers, i.e. large 
molecules made up of a combination of a few types of small molecules (monomers). 
Proteins, RNA and DNA are long sequential combinations of amino acids, ribonucleotides, 
and deoxyribonucleotides, respectively, and carbohydrates are sequential (but sometimes 
branched) combinations of monosaccharides. Therefore, a central part of anabolism is 
forming these monomers, or “building blocks” of the cell, which will later be assembled into 
functional components. 
 
Metabolism can be tuned by the cell to adjust its needs, depending on the environmental 
conditions. In this regard, the field of metabolic engineering [9] has emerged in the past 30 
years as a way of studying these metabolic decisions, and how they can be modified to favor 
production of chemical compounds with economic value, which otherwise would have to be 
synthetized using less sustainable practices, such as chemical synthesis. Making these 
modifications has become rather straightforward, thanks to recent techniques of gene editing 
[10] that allow fine-tuning the expression of any gene inside the cell to control the level of 
enzyme. However, it remains challenging to understand at the systems-level how yeast uses 
1. Background 
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its metabolism for growth and production of metabolites. In this thesis, I study metabolism 
of yeast from a holistic perspective, i.e. considering all pathways, reactions and metabolites 
at the same time. 
 
 
1.3. Genome-scale modeling of metabolism: Starting from the bottom 
 
To properly understand metabolism, we need the aid of computers. This need arises from 
our brains’ limited capacity to process information, an observation referred to as Miller’s 
law [11]. As metabolism consists of thousands of reactions and metabolites, we must rely on 
a computational representation to understand it on a systems level. In this regard, the field 
of systems biology [12] has emerged as the formal study of complex biological systems, 
using mathematical modeling and high-throughput data. In this section I review genome-
scale metabolic modeling, a “bottom-up” approach and the main technique for modeling 
metabolism in systems biology, together with the challenges that the field presents. 
 
 
1.3.1. Mechanistic models of metabolism 
 
Modeling metabolism has always been at the core of systems biology [12]. Already when 
the biochemical steps of the main metabolic pathways were being elucidated, mathematical 
models of metabolism were being developed for simulation and analysis. These models can 
broadly be classified in phenomenological and mechanistic models [13]. Phenomenological 
models, also referred to as “top-down” models, are constructed from experimental 
measurements of cellular information (oftentimes at a genome-wide level), and in general 
aim to discover previously unknown molecular interactions, using the power of statistics. 
Instead, mechanistic models are built from our understanding of singular components and 
their interactions between them, to form in a “bottom-up” approach a working model of the 
cell. In this thesis, I focus on mechanistic models of metabolism. 
 
Two main formalisms have been developed for mechanistic modeling of metabolism: kinetic 
modeling and stoichiometric modeling [14] (Table 1). In kinetic models, reaction rates, also 
referred to as fluxes, are modeled as a function of metabolite concentrations (typically in g/L 
units), using previously inferred mathematical representations of reaction mechanisms, and 
metabolite concentrations are modeled as a function of time, using ordinary differential 
equations. In stoichiometric models, sometimes referred to as constraint-based models [15], 
a pseudo-steady state is instead assumed, which dictates that under short timescales the 
accumulation of intracellular metabolites can be neglected [9]. Metabolite concentrations are 
therefore not modeled, and reaction fluxes (typically in mmol/gDWh units) are inferred by 
imposing steady-state mass balances on each metabolite. In this thesis, I explore the 
stoichiometric modeling approach, and its use for elucidating yeast physiology. 
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Table 1: Differences between kinetic and stoichiometric modeling. M is the set of metabolite 
concentrations, k the set of parameters needed a priory, v the metabolic fluxes, and LB and UB the lower and 
upper bounds, respectively, of the metabolic fluxes. 
 
 Kinetic Modeling Stoichiometric modeling 
Type of model Dynamic Stationary 
Unknown variable Concentrations: M [g/L] Fluxes: v [mmol/gDWh] 
Mass balances dM
dt
= S ∙ v(M, k) S ∙ v = 0 
Additional constraints M(t = 0) = M LB ≤ v ≤ UB 
Number of parameters Several Few 
Number of solutions Single Infinite 
Linearity Non-linear Linear 
Typical size of network <100 metabolites >1000 metabolites 
Computational time required ~minutes ~milliseconds 
 
 
A main advantage of stoichiometric models is their computational efficiency, which is due 
to their linear structure. By assuming steady state, mass balances for each metabolite yield 
simple linear relationships between metabolic fluxes: the sum of all fluxes that produce a 
given metabolite must be equal to the sum of all fluxes that consume it. This can be expressed 
as a simple equation in which fluxes, represented by a vector, are multiplied by a matrix 
known as the stoichiometric matrix (Figure 2). The columns of this matrix indicate the 
stoichiometry of reactions, and the rows indicate the mass balances for each metabolite. The 
only remaining requirement for simulations is to impose inequality constraints on fluxes, 
based on either measured data (e.g. the uptake of nutrients from the media) or known 
impossibilities (e.g. irreversible reactions) (Figure 2). In turn, kinetic models are non-linear, 
and typically take much longer to simulate [16] (Table 1). 
 
 
 
 
Figure 2: Example of stoichiometric modeling for a toy network. Mi are metabolites, Ri are reactions, vi 
are reaction fluxes, S is the stoichiometric matrix, and LB and UB are lower and upper bounds, respectively. 
Note that reactions R4 and R5 are reversible, and an experimental measurement is available for R1 (vexp). 
 
 
Another main advantage of stoichiometric models is that they require few parameters for 
simulation. Note that in the previously mentioned mass balances, no experimental 
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parameters are needed, and only a few experimental measurements are required for the flux 
inequality constraints. This is radically different for kinetic modeling, where each reaction 
mechanism is modeled with one or more kinetic parameters [17], which are not always 
readily available. Stoichiometric modeling stands then as a popular way to circumvent this 
unavailability of kinetic data. 
 
Thanks to the development of whole-genome sequencing, stoichiometric models were able 
to become genome-scale in the early 2000s, i.e. covering most metabolic pathways in the 
cell. Since then, they are also referred to as genome-scale metabolic models, or genome-
scale models (GEMs) for short. They are typically reconstructed in a semi-automatized 
manner, and account not only for metabolites and reactions, but also for genes and the 
corresponding gene-reaction relationships. Therefore, GEMs are perfectly suited for 
metabolic engineering, as they can be used to assess the effect of genetic perturbations in 
metabolism, such as knockouts or over-expressions of specific genes. 
 
However, GEMs are by no means the best modeling approach and present several 
disadvantages compared to kinetic modeling [16]. As the number of reactions in GEMs is 
typically larger than the number of metabolites, these models almost always yield an 
underdetermined problem, i.e. the number of variables is lower than the number of linearly 
independent equations. This means that the number of solutions that satisfy the requirements 
is infinite (Table 1), and additional assumptions are needed to obtain a single solution, e.g. 
assume that the cell has a metabolic objective (Section 1.3.2). Furthermore, although the 
approach is useful for predicting the values of metabolic fluxes, it tells us nothing about 
metabolite concentrations and to what degree enzymes are saturated inside the cell, which 
would be relevant information for strain improvement in metabolic engineering. Therefore, 
alternative approaches have been proposed that reconcile kinetic data into stoichiometric 
models, either for only a handful of extracellular metabolites [18] or by only using simplified 
kinetic mechanisms [19].  
 
 
1.3.2. Simulating genome-scale models: Wearing and tearing 
 
Due to their linear structure, GEMs are highly efficient to compute: a single simulation of 
the network takes less than a second of computational time in a normal desktop computer. 
Given this efficiency, in almost 20 years of progress in the field since the first GEM was 
published [20] numerous constraint-based approaches for simulation of GEMs have been 
published [21]. All these approaches require the previously mentioned constraints of mass 
balance and flux capacity (Section 1.3.1), which create what is known as a “solution space”, 
consisting of infinite possible flux distributions that satisfy these constraints. However, as 
we cannot study an infinite number of distributions, these approaches need additional 
assumptions to simplify the analysis.  
 
Constraint-based approaches can be broadly classified into biased approaches, where an 
objective function is defined, and unbiased approaches, where there is no objective function 
[21]. Here, an objective function is defined as an (often linear) combination of the fluxes in 
the network set to be either minimized or maximized. This objective function should 
represent a goal that the cell experimentally shows to try to achieve, for instance maximizing 
its biomass yield or ATP turnover [22]. An overview of some constraint-based methods is 
presented in Box 1, where flux balance analysis (FBA) stands out as the first one 
implemented [23] and one of the most popular approaches to date. Most of these methods 
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come included in computational simulation toolboxes such as the COBRA toolbox [24,25] 
and the RAVEN toolbox (Paper VII). 
 
 
Box 1: Constraint-based approaches used in this thesis to simulate flux distributions of GEMs. 
• Flux balance analysis (FBA): A biased approach in which 
an optimization problem is solved to find a single flux 
distribution that minimizes/maximizes a defined linear 
function [26]. Note that this can yield equally optimal 
alternative solutions (Figure 3). 
 
• Parsimonious flux balance analysis (pFBA): A 2-step 
optimization, where after a regular FBA simulation, the 
objective function is fixed and the absolute sum of all fluxes 
is minimized, to find the most “compact” solution [27]. 
 
• Flux variability analysis (FVA): An extension of FBA in 
which for each reaction of the network, the span that each 
flux can vary while preserving optimality is computed [28]. 
 
• Random sampling: An unbiased approach in which the 
interior of the solution space is sampled without imposing 
any objective function [29,30]. Combined with FBA, it can 
be used to sample only the optimality region (Figure 3). 
  
 
Figure 3: Results of different simulation 
approaches for a hypothetical solution 
space, using f(v) = v3 as objective 
function to maximize [15]. 
 
 
1.3.3. Evaluating quality of genome-scale models 
 
For many organisms, multiple GEMs have been developed [31]; thus, when model 
developers create a new model, they need to compare it to previously existing models of the 
same organism, if available. Additionally, model users should have an easy way of knowing 
which model is better suited for their modeling objective. An even finer distinction is to 
compare among model versions, as models are often updated to newer versions whenever 
new biochemical knowledge or tools for improving model quality are published. Several 
metrics have therefore been developed for assessing model quality, both in terms of 
coverage, consistency of biochemical knowledge, and predictive power of simulations. 
 
Typical evaluation metrics that asses coverage are the size of the model with and without 
accounting for compartmentalization (i.e. counting a metabolite only once if it repeats in 
different compartments) [32], the heterogeneity between models [33], and how well 
annotated the model is [34]. Regarding consistency, it is common to assess mass balance 
and charge balance of reactions in the model [35], network connectivity [36], and the 
existence of dead-end metabolites, i.e. metabolites that cannot be produced or consumed in 
the model, and/or blocked reactions, i.e. reactions in the model that cannot carry any flux. 
The last two metrics can be computed using FVA (Box 1). 
 
Regarding predictive power, the most popular approach is to use FBA to predict the flux 
distribution under a given experimental condition. To validate predictions, intracellular 
fluxes can be quantified using a technique known as 13C-based flux analysis [37]. However, 
this technique is experimentally challenging and restricted to only a few selected pathways; 
much more common instead is to compare flux predictions to experimental rates that are 
easier to measure, such as i) consumption/production rates of chemical compounds, and ii) 
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cellular growth. The first group of fluxes is predicted by reactions present in GEMs known 
as exchange reactions (Figure 2), which are included to allow mass to enter and leave the 
modeled system. In turn, growth can be predicted by including in the GEM what is known 
as the biomass pseudo-reaction, i.e. a mathematical representation of cell growth that lumps 
all the biomass components into a “biomass” pseudo-metabolite, which is excreted from the 
system in the same fashion of exchange reactions. The stoichiometry of this biomass pseudo-
reaction is based on the abundances of the main cellular components, which have to be 
experimentally measured, and the energy demand needed for growth, referred to as the 
growth-associated ATP maintenance (GAM), which is typically fitted together with its non–
growth counterpart (NGAM), to have the model match experimental data [23]. 
 
Another common approach for assessing predicting performance of GEMs is the ability of 
the model to reproduce experimental gene deletions, which is typically achieved by blocking 
the reactions associated to each gene and observing if the model is able to predict growth 
[38]. Caveats when assessing this metric (such as modeling setup, growth thresholds and 
experimental data) are available in Paper I. 
 
It is important that all previously introduced metrics are readily available for anyone to 
compute on any model. As part of my PhD studies, I have developed a toolbox that measures 
most of the abovementioned metrics for comparing yeast models, available at 
https://github.com/BenjaSanchez/yGEMe. However, this toolbox is rather organism-
specific and cannot be easily implemented for any model. In this regard, recent efforts that 
compute a suit of metabolic model tests automatically for any model (Paper VIII) are a 
great advantage for new models being developed. 
 
 
1.3.4. Integration of omics data in genome-scale models: The battle of evermore 
 
As previously mentioned, an important disadvantage of GEMs is that their simulations are 
undetermined, i.e. an infinite number of solutions are attainable if we only use mass balances 
and flux capacity constraints. Therefore, numerous methodologies have been developed for 
further constraining the solution space by adding different types of so-called omics data, i.e. 
experimental data that measures complete layers of biomolecular information in a high-
throughput way [39]. By integrating these data, GEMs become a combination of the 
“bottom-up” and “top-down” approaches in one framework. The most commonly used types 
of data for this purpose are transcriptomics, i.e. gene expression; interactomics, i.e. gene-
gene, protein-gene and protein-protein interactions; proteomics, i.e. protein intracellular 
levels; thermodynamics, i.e. reactions’ physicochemical properties; kinetics, i.e. operational 
mechanisms of reactions; metabolomics, i.e. intracellular metabolite levels; lipidomics, a 
type of metabolomics data only accounting for lipid species; and fluxomics, i.e. 
measurements of flux values inside the cell or between the cell and its environment. A 
detailed explanation of each type of omics data together with examples of integration into 
GEMs of yeast is available in Paper I. 
 
In general, omics data can be integrated in either a “hard” approach or a “soft” approach. In 
hard approaches, the data is directly used as additional numeric constraints (either as 
equalities or inequalities) on the metabolic fluxes, whereas in soft approaches no direct 
constraints are used and instead the model is simulated either with an objective function 
designed to come closer to the omics data levels, or as is to be later compared to the omics 
data [15]. In this thesis, I will mainly use the hard approach in my analysis, by using absolute 
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abundance of some biomolecules as constraints on metabolism. I call these “abundance” 
constraints. 
 
There are currently many challenges when it comes to integrating omics data into GEMs. 
An important challenge, addressed further on in this thesis (Chapter 4), is the integration of 
proteomics, the measurement of every single intracellular level of protein inside the cell. 
This type of omics data has become in the past years more and more popular, especially with 
the development of mass spectrometry (MS) as a genome-wide approach for quantifying 
absolute protein copy number [40]. However, compared to the rest of the omics data types, 
it is the one that has been the least used in combination with GEMs (Paper I). Another 
challenge is the integration of several layers of omics data at the same time, which presents 
a set of challenges of its own regarding data consistency, which will be highlighted 
throughout this thesis. 
 
 
1.4. Genome-scale models of yeast: Fifteen years in the light 
 
The first GEM of yeast was published in 2003 [41]. Not only was it the first GEM for S. 
cerevisiae, but also the first eukaryal GEM; it comprised of 1175 reactions, 584 metabolites, 
708 genes and 3 different cellular compartments: cytosol, mitochondria and extracellular 
space. Since then, 13 additional models have been released using this model as original 
template (Figure 4A). Each of these models has either provided additional simulation 
capabilities and/or improved coverage [42,43], mostly in terms of reactions and metabolites 
(Figure 4B, Table 2). Among these models, the consensus genome-scale network 
reconstruction project (formerly yeastnet, currently yeast-GEM) deserves a special mention, 
as it was created from the merge of two different models and manually curated using a 
‘jamboree’ approach where several yeast research groups worked together at a three-day 
event [44]. Afterwards there has been several new published versions [45–49] and it is to 
date the main simulation-ready knowledge base of yeast metabolism.  
 
 
 
 
Figure 4: Genome-scale models of yeast. (A) Schematic history of GEMs in yeast. The models that are part 
of the yeast consensus GEM project are highlighted in light blue. (B) Number of reactions, metabolites, 
genes and compartments in all GEMs of yeast. 
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Table 2: Additional details of all GEMs published of yeast. 
 
Name Year Novelty / additional details Reference 
iFF708 2003 First GEM of S. cerevisiae. [41] 
iND750 2004 Increased the number of compartments to eight. [50] 
iLL672 2005 Tested gene essentiality predictions under five environmental conditions. [51] 
iIN800 2008 More detailed lipid metabolism. [52] 
Yeast 1 2008 First consensus genome-scale network reconstruction. [44] 
iMM904 2009 Improved gene essentiality predictions. Integrated metabolomics data. [53] 
Yeast 4 2010 More detailed lipid metabolism. Allowed constraint-based simulations. [45] 
iAZ900 2010 Reconciled growth prediction inconsistencies. [54] 
Yeast 5 2012 Improved sphingolipid metabolism. [46] 
iTO977 2013 Decreased number of compartments and increased unique reactions. [32] 
Yeast 6 2013 Refined coverage and improved anaerobic predictions. [47] 
Yeast 7 2013 Enhanced fatty acid, glycerolipid and glycerophospholipid metabolism. [48] 
iSce926 2015 Improved Gene Essentiality and Synthetic Lethality predictions. [55] 
Yeast 8 2018 First yeast model tracked using a version control system. [49] 
 
 
Previous studies have compared some of these models in terms of prediction capabilities. 
One study showed that models of yeast that have been manually curated are better in 
predicting intracellular fluxes when compared to experimental measurements from 13C-
based flux analysis [56], highlighting the value of manual curation in the development of 
GEMs. Another study showed that when comparing the similarities between models, they 
tended to cluster based on the research group that had developed them, and that no model 
was better than the rest when predicting gene essentiality. Here, it is important to note that 
the biomass pseudo-reaction has remained almost entirely the same for all yeast models [57], 
suggesting that a potential improvement for prediction performance could be to account for 
more biomass components, using more detailed abundance data. 
 
The previously introduced GEMs of yeast have been used in numerous occasions for 
metabolic engineering applications, such as for assessing mutant phenotypes [58], increasing 
production yields [59], and assessing optimal co-cultivation strategies with other species 
[60]. These and more applications are reviewed elsewhere [16]. With the development of 
new experimental and computational methods for improving model quality, I expect the 
number of applications to continue increasing in the future. 
 
 
1.5. Aims and significance 
 
Until here, I have introduced the genome-scale modeling approach, and how it has been 
applied to better understand yeast physiology (Paper I). In particular, I introduced the 
concept of “abundance constraints” as constraints that are defined by omics data containing 
absolute quantities of biomolecules. These constraints could be highly useful, as they 
represent physical limitations inside the cell, as opposed to ad-hoc constraints. This thesis 
will explore abundance constraints in yeast metabolism, by connecting GEMs to two 
different levels of omics data: lipidomics (measurements of lipids) and proteomics 
(measurements of proteins, particularly enzymes). 
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The thesis is divided in three parts (Figure 5). In the first part (Chapter 2), I lay two 
foundation stones to properly address the integration of omics data in GEMs. The first 
foundation stone is traceability of GEM development, which is needed to guarantee that the 
performed analysis can be reproduced by others. For this, I introduce a version control 
strategy for recording changes in GEMs (Section 2.1). The second foundation stone is 
consistency of omics data, which is fundamental if we are to analyze several layers of 
information combined. For this, I present a dataset of S. cerevisiae grown under different 
levels of environmental stress: heat stress, osmotic stress and ethanol stress (Paper II). 
Understanding and properly modeling metabolism is essential for comprehending the stress 
response in S. cerevisiae, as stress causes increased energy demand and reorganization of 
the biomass composition.  
 
 
 
 
Figure 5: Graphical abstract of the research presented in this thesis. Top left block: The addition of lipid 
constraints through SLIMEr enables a flexible way for the model to satisfy lipid requirements. Top right 
block: The addition of enzyme constraints through GECKO allows to compute enzyme usage of every 
enzyme in the model at varying experimental conditions. Bottom block: Traceability model development 
through version control (left side) and consistent data integration through multi-omics studies (right side) are 
foundation stones for computing abundance constraints in metabolism. 
 
 
Having set these foundation stones for proper data integration, In the second part of the thesis 
(Chapter 3) I investigate lipid metabolism. Here, a recurrent problem facing GEMs is to 
correctly represent lipids as biomass requirements, due to numerous combinations of 
individual lipid species and the lack of fully detailed data. In this thesis I present SLIMEr 
(Paper III), a formalism for correctly representing lipid requirements in GEMs using 
commonly available experimental data. I  implement this approach in yeast-GEM, to make 
it possible to explore the flexibility of lipid metabolism at varying experimental conditions. 
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In the final part of the thesis (Chapter 4), I turn to enzymes and their relationship to 
metabolism. First, as GEMs do not account for enzymatic information, I present GECKO 
(Paper IV), a method for including enzyme constraints in GEMs based on kinetic and 
proteomics data. These enzyme constraints are implemented in yeast-GEM to investigate 
physiological behavior that could not be explained using regular genome-scale modeling. 
Secondly, as notorious variability is observed in the proteomics data measured in Paper II, 
I asses the protein quantification technique used to generate said data. I achieve this by 
introducing a separate dataset that focuses on biological and batch replicability (Paper V), 
and by measuring in this dataset accuracy and precision of different variants of the protein 
quantification methodology. Finally, I apply the GECKO formalism on the stress dataset, to 
create enzyme-constrained models for each of the experimental conditions, with flux 
limitations based on the proteomics detected values (Paper VI). These models are then 
analyzed to find trends in enzyme usage between and within stress types. 
 
The analysis presented in this thesis is an example of how integration of mathematical 
modeling and omics data can yield novel insight into cellular physiology. 
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2. Foundation stones for the next generation of 
genome-scale models 
 
 
As mentioned earlier, the field of genome-scale modeling has been moving more and more 
towards the integration of multiple levels of omics data, to infer previously unknown 
physiological behavior [61]. Particularly, this thesis will explore methods for connecting 
GEMs to two different levels of omics data: lipidomics and proteomics. However, it is 
relevant to set some foundation stones before proceeding with any further analysis. In this 
chapter I go through two main concepts that I see as the basis for robust genome-scale 
modeling: traceability of the model development, and consistency of the data used. 
Concerning traceability, I present a sustainable way of developing genome-scale models 
which uses version control tools as a way of keeping track of every change in a model, to 
guarantee that no unexpected changes are introduced that could decrease model quality. 
Concerning consistency, I present a multi-omics dataset of yeast grown under different levels 
of stress (Paper II) that will be used throughout this thesis, to guarantee that the different 
types of data we integrate into the model are consistent amongst themselves. 
 
 
2.1. Sustainable development of genome-scale models: No surprises 
 
An important challenge in genome-scale modeling is to properly evaluate GEMs, to 
determine if the changes we have done to a model are improving coverage and/or prediction 
performance (Section 1.3.3). However, a challenge that comes with this is to properly keep 
track of the changes as we develop a given model, so that we can guarantee reproducibility 
of our research [62]. In this section, I go through a new way of recording changes and 
developing GEMs that some models in my research group have started to follow. This 
section is not included in any of the papers that are part of my thesis, although the concept 
is briefly introduced in Paper VII, and the implementation of these ideas in the consensus 
GEM of yeast is part of Paper X. 
 
Due to the size of metabolic networks, it is challenging to keep track of changes as we 
develop a GEM, making comparisons among different versions of the model difficult 
(Figure 6A). When only one researcher develops the model this can perhaps be overcome 
by ensuring that every change is manually recorded in some log; however, this becomes 
increasingly harder if two or more researchers develop the model together, as different tasks 
might overlap in the same components of the model, e.g. correcting stoichiometry of 
reactions and including reaction annotation might end up changing the same reaction, 
generating a conflict which is hard to resolve later. Additionally, when a group of researchers 
are developing a model it would also be beneficiary to have an on-line alternative for model 
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developers to quickly share changes to the model, and for users to obtain the latest version 
of the model and contact the developers if any problems with the model are detected. 
 
 
 
 
Figure 6: Different strategies for developing a GEM. (A) By editing the model without any version 
control system, it is hard to assess what are the differences between two versions of the model, as even if they 
would be of the same size (models 2.0 and 2.1), they could have differences.  (B) Thanks to version control, 
every change to the model is registered in a commit, showing what was the change, who did it and when. 
 
 
In software development, these problems have been solved with version control, i.e. the 
practice of automatically tracking changes to a file or set of files over time [63]. When using 
a version control system, a group of files is organized in a so-called “repository”, and 
changes performed to the files are grouped in “commits”, which later can be queried 
individually to understand the changes that are being introduced to the files. Git (https://git-
scm.com/) is currently the most common alternative for version control, due to its efficiency 
and scalability. Additionally, web services such as GitHub (https://github.com/) and GitLab 
(https://gitlab.com/) offer free on-line hosting of Git repositories, for people to 
collaboratively develop code. Version control practices have become the standard to 
guarantee reproducibility in most scientific fields that uses computational analysis; it is then 
not hard to imagine that such a system could be implemented for tracking GEMs as well 
(Figure 6B), as GEMs are typically stored in file formats compatible with version control. 
 
Even though several software for automatic GEM reconstruction exist [64–66], they are not 
designed for model storage and therefore do not account for any type of version control. 
Some alternatives for hosting models with version control do exist [67,68], but they rely on 
dedicated software (limiting the capabilities of model development), and more importantly 
do not provide an easy way of delivering the model to users and to allow the engagement of 
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the community. We therefore need a simple tool that can keep track of changes, allow work 
in parallel, minimize conflicts (if they appear), publicly store different versions of the model 
with a detailed log of every change, and allow users a straightforward way for contacting the 
developement team for issues and/or sending their own contributions. 
 
Here, I outline a strategy for storing and developing a GEM with version control tools to 
promote reproducibility and open collaboration. The strategy has been implemented in yeast-
GEM, the continuation project of the consensus GEM of S. cerevisiae [44]. In this strategy, 
Git is used as version control tool to track changes of the model files, and GitHub as hosting 
service to provide all files to the community. The model can be modified locally using 
Matlab® and saved using a RAVEN/COBRA wrapper function that stores the model in three 
different formats: the interchange systems biology markup language (SBML) format (.xml), 
meant for simulations across programming languages and toolboxes, and two summarized 
text files (.txt and .yml), meant for easier visualization of changes in GitHub or any Git 
graphical user interface (GUI) client (Figure 6B). The researcher modifying the model 
should also provide the corresponding data/scripts used for modifying the model, and use 
semantic commit messages [69] to describe what has been done in the model. This way, by 
looking at the history of the repository, anyone can know what has been changed, who did 
it and why, achieving a 100% traceable history of the model development. 
 
To allow multiple developers to work in parallel in the model, and users to submit their own 
contributions, the strategy also entails a branching model. In version control, a “branch” 
refers to a copy of the files in the repository that can be modified with extra commits without 
modifying the rest of the project. In our strategy for GEM development, three different types 
of branches are accounted for [70] (Figure 7): a single “master” branch, which only gets 
updated with official new versions of the model; a single “development” branch, where all 
of the finalized work by the development team is kept; and several “feature” branches, which 
have the work in progress of each developer of the team (although one developer might have 
more than one branch). Both master and development branches can only be modified by an 
administrator of the repository. 
 
 
 
 
Figure 7: Diagram exemplifying how the consensus GEM of yeast allows for work in parallel by 
multiple collaborators. Different colors indicate the three different types of branches the repository 
contains. The lock icons indicate the branches that only the administrator can access. This scheme is a 
simplification of a popular branching model [70]. 
2.2. Multi-omics dataset of S. cerevisiae 
16 
 
With this system, each researcher can work separately on their own branch, without 
interfering with the work of others. Once they have finished their specific project, they can 
request the administrator to merge their changes into the development branch, by opening 
what is known as a “pull request”, which needs to first be reviewed and accepted by someone 
else in the development team. Any conflicts are easily spotted at this point and must be 
resolved before merging. After this reviewing process, the administrator of the repository 
proceeds to integrate the changes into the development branch. Once enough work has been 
accumulated to the development branch, the administrator proceeds to release a new version 
of the model, by merging the changes in the development branch to the master branch. 
 
Additionally, developing GEMs using this approach has the advantages of other software 
hosted in GitHub: Users can open issues if they detect errors in the model and/or missing 
biochemical information, and they can comment on existing issues, providing their expertise. 
Developers can display the work they are currently doing by organizing it in projects, to let 
users know if a certain feature in the model will soon be implemented. Finally, the 
administrator can tag specific commits (Figure 7) as stable releases, so users can utilize 
those versions of the model for simulation purposes. These releases also include the model 
in Matlab® (.mat) and Excel® (.xlsx) formats, meant for quick simulation and data-
navigation, respectively. 
 
In my group, we have been using this system for development of GEMs for the past 2 years. 
In the case of yeast-GEM, it has been beneficial as a tool for working in parallel and 
reviewing each other’s contributions. When a problem in the model performance has been 
detected, it has been quite easy to trace the source of the problem and fix it. Finally, it has 
increased collaboration between model developers, and allowed engagement of the yeast 
community in the project. Several modifications done to the model throughout this thesis 
have been included via pull requests into yeast-GEM, the main example being the addition 
of SLIME reactions (Chapter 3). 
 
In conclusion, version control is not only essential for reproducibility when developing code 
in research, but can also be adapted to develop GEMs in a transparent and reproducible 
fashion, minimizing conflicts when working in parallel, and engaging the user community. 
The implementation of this version control system for yeast-GEM, including all releases plus 
detailed guidelines for users, developers and administrators, is available at 
https://github.com/SysBioChalmers/yeast-GEM. 
 
 
2.2. Multi-omics dataset of S. cerevisiae 
 
As shown in Section 1.3.4, integrating omics data in GEMs is a common practice to further 
constrain the solution space and improve metabolic predictions. As a plethora of published 
experimental data is available, the most common way researchers do this is by using different 
published datasets. However, a challenge emerges when several layers of data are used 
together, as most often these layers have been measured in separate experiments, of which 
each might have been conducted with a different strain of the same organism, or a different 
experimental setup. As these variables can exert an important influence on the measured 
data, the corresponding layers of data might have inconsistencies between them, resulting in 
unfeasible simulations when integrated in a GEM. Therefore, studies that measure several 
layers of information at the same time [71] are valuable resources for consistent omics 
integration into GEMs. In this section I go through Paper II, wherein a dataset was generated 
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of S. cerevisiae grown under several conditions of stress. As this thesis focuses on the 
integration of data in GEMs for inferring novel observations, the focus of this section is on 
the data presented in Paper II. 
 
Understanding the response of S. cerevisiae to different conditions of stress is of high 
importance for biotechnology applications [72], as doing so can enable the development of 
resistant strains that can endure harsher conditions and/or improve product yields [73]. 
Among the different types of stresses yeast can face, some of the most commonly studied 
ones are heat stress [74], ethanol stress [75] and osmotic stress (by increasing the 
concentration of salt) [76]. Considering the modeling tools introduced in Section 1.3, it is 
valuable to gather omics data on the adaptation of yeast to these stresses, to look into the 
physiological responses from a systems biology perspective, and particularly to see how 
metabolism adapts to cope with said stresses. 
 
To measure these data, we need an appropriate experimental setup. There are three main 
bioreactor setups that are routinely used in industrial biotechnology: batch, fed-batch, and 
chemostat [77]. The simplest one is the batch setup, where the organism is inoculated into a 
perfectly stirred vessel containing growth media, so that the organism consumes the nutrients 
in the media and replicates, until the media becomes limiting, i.e. runs out of one of the basic 
elements needed for growth, e.g. carbon. This setup allows measuring the dynamic response 
of the organism to variable substrate concentrations. The fed-batch setup starts in the same 
way as a batch setup, only that as soon as the media has become limiting, a feed of fresh 
media is slowly added to the vessel, to maintain low levels of the limiting element while still 
allowing cells to grow. This is especially beneficial if we wish to achieve high levels of 
biomass, as by keeping cells growing at a low growth rate we avoid production of secondary 
products that might inhibit growth. Finally, the chemostat setup (Figure 8A) is similar to the 
fed-batch setup, only that there is both a feed into the vessel and an outlet from the vessel, 
tuned so that the culture volume remains constant. By doing so, we can control the specific 
growth rate of the cells at the desired dilution rate of the vessel (the feed rate divided by the 
volume of media). In this study, the chemostat setup was used, as it is best suited for 
capturing the steady-state physiological response of cells, which will be later integrated with 
the genome-scale modeling approach. 
 
 
 
Figure 8: Experimental setup in this study. (A) The chemostat setup used to cultivate yeast, and all 
measurements performed on the extracted samples. The measurements used in this thesis are highlighted in 
light blue. (B) Summary of all studied stress conditions. The two different text colors (black/white) indicate 
the two different groups in which the MS data was measured. 
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Briefly, S. cerevisiae, strain CEN.PK113-7D, was grown in glucose-limited chemostats at a 
specific growth rate of 0.1 h-1. The cultivations used minimal media, i.e. containing the 
minimum number of nutrients to allow growth, and were kept aerobic by sparging air so that 
the partial pressure of oxygen (pO2) was always above 30%. Furthermore, a pH of 5.5 and a 
stirring rate of 600 RPM were kept constant for all chemostats. Using this setup, 14 
conditions were assessed, with each one in triplicate (Figure 8B): a reference condition, 
grown at 30ºC and with no NaCl or ethanol; 3 levels of temperature stress; 7 levels of osmotic 
stress; and 3 levels of ethanol stress. Note that only 3 of the osmotic stress levels are included 
in Paper II, whereas the other 4 levels were separately generated for Paper VI. 
 
For all the above-mentioned conditions, samples were collected from the steady state to 
analyze several layers of biological information (Figure 8A). The consumption/production 
rates of glucose, ethanol, acetate and other organic acids were inferred by measuring with 
high-performance liquid chromatography (HPLC) the concentrations of these substances in 
the outlet of the chemostat and performing a mass balance to deduce how much are cells 
consuming/producing. A similar analysis was done for the consumption of O2 and 
production of CO2, as the gases entering/leaving the system were also measured. All these 
rates can be compared to what the model would predict as exchange reaction fluxes 
[mmol/gDW] (Paper VI), or instead used as constraints on the simulations (Paper III). 
 
Several established protocols exist for measuring the biomass composition, i.e. the mass 
fraction [g/gDW] that each component (protein, RNA, carbohydrate, etc.) take up inside the 
cell. Protein content was measured using a commercial assay kit, total RNA content using 
spectrophotometry, and trehalose and glycogen (two of the abundant carbohydrates in yeast) 
were separately isolated, hydrolyzed and measured with HPLC. Regarding lipids, ergosterol 
was detected with HPLC, and all other lipids were measured using both HPLC and an 
esterification process, as it will be explained in more detail in Section 3.1. 
 
Absolute protein abundances [nmol/gDW] were also measured, by performing what is 
known as peptide-based shotgun MS [78], where the protein fraction is extracted, digested 
with a protease, and the resulting mix of peptides separated in a liquid chromatography (LC) 
column and detected using an MS instrument and a recognition software [79]. Afterwards, a 
technique known as intensity-based absolute quantification (iBAQ) [80] was used, which 
relies on an external commercial standard to infer the relationship between the peptide MS 
intensities and the corresponding protein abundances. This relationship was used to infer the 
protein abundances of a separate sample, consisting of proteins from a lysine auxotrophic 
strain of S. cerevisiae fed with heavy 15N, 13C-lysine. Finally, these values were used to infer 
the abundances of all the samples from the study with another approach known as stable 
isotope labeling by amino acids in cell culture (SILAC) [81]. When performing SILAC, we 
first mix in equal amounts each sample with the previously mentioned auxotrophic sample 
and then perform the MS analysis. This will yield, for each peptide (and therefore for each 
protein), two separate MS intensities, and as we know the abundance of one of them (thanks 
to the iBAQ technique), we can infer the abundance of the other. 
 
Two additional layers of information are also accounted for in Paper II: transcriptomics 
data and degradation rates of proteins. Absolute levels of mRNA were inferred using next 
generation sequencing data from a previous study [82] combined with a commercial RNA 
quantitation assay to generate a standard curve that was applied on all transcripts and all 
experimental conditions. Degradation rates of proteins, referred to sometimes as protein 
turnovers, were inferred by using the previously mentioned SILAC technique to capture the 
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dynamic response of the proteome in the lysine auxotrophic strain of S. cerevisiae when 
transitioning from a feed with unlabeled to labelled lysine. Nonetheless, these two levels of 
information were not used in connection with genome-scale modeling in this thesis, so they 
will not be further analyzed here. The results for the other three types of measurements 
(Figure 8A) are summarized below. 
 
It can be observed that exchange fluxes, the most direct way of assessing the metabolic 
response, undergo dramatic changes as stress levels increase. In the case of heat stress 
(Figure 9A), this only occurs at 38ºC, at which point yeast starts fermenting, i.e. producing 
ethanol. In the case of osmotic stress (Figure 9B), a change in the O2 consumption and CO2 
production is only observed from 0.6 M, and production of ethanol only from 1.2 M. In fact, 
this observation led to measure additional levels of osmotic stress (0.8, 1.0, 1.2 and 1.3 M) 
for Paper VI. Finally, in the case of ethanol stress (Figure 9C), co-consumption of both 
glucose and ethanol were observed for all conditions, gradually increasing the uptake of 
glucose and decreasing the uptake of ethanol as the level of stress increased. 
 
 
 
 
Figure 9: Overview of the experimental data. (A-B-C) Metabolic exchange rates at increasing levels of 
temperature (A), osmotic stress (B) and ethanol concentration (C). (D) Biomass composition at reference 
conditions. The undetected carbohydrate content is estimated from literature [41]. (E) Histogram of the 
protein abundances at reference conditions. (F) PCA of the proteomics data. Colors represent the stress types 
and marker sizes represent the stress level. The amount of variability that each component represents is also 
indicated. 
 
 
Regarding the biomass composition (without accounting for water), it was seen that at 
reference conditions around 45% of the biomass corresponds to protein (Figure 9D); a 
fraction that increases further at higher levels of stress (Paper II). Note that from the 
carbohydrate fraction, which at reference conditions is known to be close to 40%, a large 
proportion was not measured, which is associated mainly to mannan and glucan [41]. For 
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the lipid fraction, which is close to 4% at reference conditions, around 80% of it corresponds 
to structural lipids (phospholipids and ergosterol), whereas the rest is primarly storage lipids 
(triglycerides and sterol esters). 
 
Finally, regarding the proteomics data, around four orders of magnitude of variation were 
observed (Figure 9E) with a median protein abundance of 0.83 nmol/gDW, which is 
equivalent to ~6,500 molecules/cell, assuming an average cell mass of 13 pg. This protein 
distribution changes as the stress level increases, as can be inferred from a principal 
component analysis (PCA) (Figure 9F), a method that uses an orthogonal transformation to 
display in two dimensions all protein abundances under all conditions. Note here that most 
of the variation within the data is explained by the first component (x-axis), and that the two 
separated groups observed correspond to the separate times in which the proteomics data 
was measured (one for Paper II and one for Paper VI). The implications of this observation 
and different ways to address it are presented in Chapter 4. 
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3. Abundance constraints: Lipids 
 
 
Lipids are essential to cells as the main membrane component; they have played a key role 
during evolution towards forming cells [83], as without them cells would not have become 
a self-contained unit. It is therefore essential to properly account for lipids when simulating 
metabolism. However, this poses a computational challenge, as there are many different 
combinations of lipids and most of them are hard to measure directly. In this chapter I go 
through Paper III, in which SLIMEr, a method for including typical lipid data in a GEM, 
was developed and implemented in the consensus GEM of yeast. The implementation of 
SLIMEr lead to an improved representation of lipid requirements, and allowed analysis of 
the high flexibility of lipid metabolism. 
 
 
3.1. The challenge of integrating lipid data in genome-scale models 
 
As previously introduced, simulation of GEMs relies heavily on the definition of a biomass 
pseudo-reaction [57,84], which consists of the abundances of the cell’s building blocks. In 
the case of proteins, RNA and DNA, abundances are straightforward to obtain 
experimentally, as they are polymers built out of combinations of 20 amino acids, 4 
ribonucleotides and 4 deoxyribonucleotides, respectively. Therefore, it is enough to isolate 
the corresponding fraction and detect the proportion of each unit, which can be achieved for 
amino acids using HPLC and for DNA and RNA using nucleotide sequencing [85]. 
Abundances are also relatively simple to obtain for carbohydrates, as while many types of 
carbohydrates are found in nature [86], specific organisms tend to contain only a few; in the 
case of yeast, most of its carbohydrate content are four different polysaccharides (glycogen, 
trehalose, mannan and glucan), which can be measured using standard protocols [87].  
 
Obtaining lipid abundances is, however, more challenging. Most lipids are characterized by 
one or more nonpolar acyl chains, sometimes referred to as “tails”, with varying length and 
number of saturations, connected by a smaller molecule referred to as “backbone”, which 
defines the class each lipid belongs to. In yeast, over 20 different lipid classes and around 10 
different acyl chains are normally expressed (some common examples are illustrated in 
Figure 10). As many enzymes that produce these lipids are not specific to particular acyl 
chains, practically any combination of backbone and acyl chains can be produced, yielding 
over 1000 different lipids yeast theoretically could express, out of which close to 250 have 
been experimentally detected [88]. Measuring each single lipid species is therefore 
challenging, and hence very few GEMs account for a biomass pseudo-reaction that has the 
abundances of all lipids [89]. 
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Figure 10: Some of the different types of lipid backbones and acyl chains that are commonly observed 
in yeast. Note that almost any possible combination of backbone and acyl chain(s) is theoretically possible. 
A much more common approach for measuring lipid data is to independently measure 
abundances of each lipid class and each acyl chain. The former can be achieved with what 
is referred to as lipid profiling, which uses HPLC for separating the lipid classes (as lipids 
within the same lipid class will elute with a similar retention time in a chromatography 
column) [90,91], and the latter by an esterification process known as fatty acid methyl ester 
(FAME) analysis, which separates all acyl chains from the corresponding lipids, in 
connection with a gas chromatography (GC) for separating each individual acyl chain 
[92,93]. Therefore, GEMs have been adapted to depend on these types of lipid data, using 
either a “restrictive” approach or a “permissive” approach. 
In the restrictive approach, a fixed acyl chain distribution is enforced on all lipid species, by 
creating a generic acyl chain pseudo-metabolite out of a combination of all acyl chains in a 
ratio that is based on the FAME data, which will then be the only acyl chain available for 
constructing any lipid species [52,94]. These generic lipid species are afterwards pooled 
together with a lipid pseudo-reaction, in a ratio that is based on the lipid profile data. The 
main disadvantage of this approach is that all lipid classes will be fixed to follow the same 
acyl chain distribution, which is known to vary significantly among lipid classes at different 
experimental conditions [95,96]. 
In the permissive approach, a lipid pseudo-reaction is also defined using the lipid profile 
data, but the generic lipids are allowed to be created from any specific lipid species [46,97]. 
The main disadvantage of this approach is that FAME data is disregarded, so the model is 
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free to choose any acyl chain for building up its lipids, which in practice will lead to lipids 
consisting mainly of short acyl chains, as those are less costly to produce in terms of energy 
requirements. These simulations would then be biased if longer acyl chains are 
experimentally detected. Consequentially, there is a need for an approach that can use both 
lipid class and acyl chain data, without enforcing a predetermined distribution. 
3.2. SLIMEr: Split and conquer 
To solve the above-mentioned challenges, we need to impose a separate constraint to each 
of the two “measurable entities” presented, i.e. the lipid backbones and the lipid acyl chains. 
However, as these entities are bound to the same metabolite in the model, we first need to 
mathematically represent the separation of both entities. Here I present SLIMEr, a method 
that adds reactions which Split Lipids Into Measurable Entities (SLIME); for each lipid 
species in the model, SLIMEr will add a pseudo-reaction that splits the molecule into its 
backbone and its different acyl chains. The stoichiometry of these reactions is proportional 
to the molecular weights of the associated entities (Figure 11), to convert molar flux 
[mmol/gDWh] into mass flux [g/gDWh], as the measured abundances typically come in 
mass units. 
Figure 11: The SLIMEr formalism to improve lipid representation in GEMs. The active fluxes for a 
hypothetical flux simulation are highlighted in light blue. Top left corner: A restrictive approach for lipid 
metabolism results in all lipid classes having the same acyl-chain distribution. Bottom left corner: A 
permissive approach results in all lipid classes using the least energy expensive acyl-chain. Middle: Pseudo-
reactions added to the model by SLIMEr. Right side: SLIMEr allows the model to satisfy at the same time 
the lipid class and acyl-chain distribution. 
As now backbone and acyl chains are separated for each lipid, each of the two groups can 
be constrained. For this, SLIMEr adds 3 lipid pseudo-reactions (Figure 11): the first one 
pools together all backbones into a generic backbone, using the abundance data from lipid 
profiling as stoichiometric coefficients. The second one pools all acyl chains into a generic 
acyl-chain, using the abundance data from FAME analysis as stoichiometric coefficients. 
Finally, the third pseudo-reaction merges the generic backbone and generic acyl chain into 
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a generic lipid, which in turn goes into the biomass pseudo-reaction. Note that for the first 
two pseudo-reactions, as the abundances [g/gDW] are used for the stoichiometry, the 
incoming mass flux [g/gDWh] is now converted into lipid turnover [1/h], compatible with 
the biomass specific growth rate. Additional details on the formalism of this method are 
available in Paper III. 
 
SLIMEr is therefore a truly unbiased approach compared to the restrictive and permissive 
approaches; on one hand, it allows FAME data to be used as input to the model, which in 
the case of the permissive approach would be neglected, yielding predictions biased towards 
shorter acyl chains. On the other hand, it does not enforce data onto each lipid class, which 
in the case of the restrictive approach would also bias the lipid distribution, as different lipid 
classes exhibit substantially different experimental acyl chain distributions (Figure S2 in 
Paper III). 
 
 
3.3. Improvement of the yeast model with the addition of SLIME reactions 
 
SLIMEr was implemented in the yeast consensus GEM presented in Section 2.1, which until 
then was using the permissive approach for representing lipid requirements. For constraining 
the new lipid pseudo-reactions, the lipid profile and FAME data from Paper II were used. 
To guarantee coherence between the different sources of data, the lipid class abundances 
were rescaled to add up to the equivalent amount detected by FAME analysis, and the 
biomass composition was scaled to add up to 1 g/gDW [98]. After these modifications, the 
model remained of a similar size, with only 17 additional metabolites and 24 additional 
reactions. In the following, I refer to the original model as the “permissive” model, as yeast-
GEM used the permissive approach until this point, and the resulting model as the 
“enhanced” model. 
 
Both models were simulated under the reference condition of the stress dataset, constraining 
all measured exchange fluxes and using the maximization of ATP maintenance as objective 
function with a pFBA approach [27]. By using SLIMEr, the enhanced model is forced to 
have the same acyl chain distribution as the experimental data, whereas a permissive model 
prefers mostly shorter acyl chains (Figure 12A). SLIMEr is hence appropriate if we wish to 
have a model that simulates an experimentally meaningful acyl chain distribution. 
 
Additionally, an FVA [28] of each group of SLIME reactions illustrated that the enhanced 
model retains a high flexibility, i.e. it has a wide range of possible acyl distributions that it 
can choose from (Figure 12B). Therefore, SLIMEr does not restrict the model excessively 
and is well-suited to study different experimental conditions where the lipid distribution 
might change significantly. Furthermore, the model achieved this new lipid configuration by 
only spending an additional 0.4% of the ATP maintenance needed in the model for unknown 
processes, a value that remained relatively constant at increasing levels of stress (Figure 3C 
in Paper III). This implies that achieving proper lipid compositions does not take a 
significant amount of additional energy compared to all metabolic costs, and physiological 
predictions of the model will overall remain similar after the addition of SLIME reactions. 
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Figure 12: Implementation of SLIMEr in the consensus genome-scale model of yeast. (A) Acyl chain 
distribution at reference conditions for the permissive model (free to choose any acyl chain) and enhanced 
model (enforced to follow the experimental distribution). (B) Acyl chain breakdown predicted by the 
enhanced model, for each lipid class. Thick black lines are pFBA predictions and colored bars are the FVA 
allowed ranges. (C) PCA of lipid distributions experimentally measured and predicted by both models. 8 
experimental conditions were assessed in total, and for each condition each model was simulated 10,000 
times using random sampling and plotted with a different yellow/blue tonality, respectively. 
I further tested the utility of SLIMEr by constructing condition-specific models for an 
additional dataset of 8 different experimental conditions, where 250 lipid species were 
measured [88], out of which 102 lipids (over 80% by mass) were present in the model. To 
construct the models, the lipid class abundances and acyl chain abundances were calculated 
from the measurements of specific lipid species. By performing random sampling [30] of 
both the permissive and enhanced models under all 8 experimental conditions, it is observed 
that the enhanced model is able to have a much closer lipid distribution to the original 
experimental values (Figure 12C). Nonetheless, the variability of the experimental data 
remains lower than the variability of model predictions; this suggests that even though there 
is a theoretically high level of flexibility in lipid metabolism, yeast has a high level of 
regulation in place to constrain its lipid composition depending on the environmental 
conditions [95]. 
In conclusion, by implementing SLIMEr the enhanced model i) enforces acyl chain 
requirements without decreasing the network flexibility nor significantly increasing the 
metabolic energy demand, ii) better predicts lipid abundance distributions, and iii) can 
compute the lipid requirements of transitioning between conditions. SLIMEr is available at 
https://github.com/SysBioChalmers/SLIMEr, and its implementation in the consensus GEM 
of S. cerevisiae is available from version 8.1.0 [99] onward. 
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4. Abundance constraints: Enzymes
Enzymes are cellular components that enable life as we know it, as they catalyze thousands 
of reactions inside the cell that otherwise would take much longer to occur or would not 
happen at all. As they are so closely related to metabolism, there has been a high interest in 
the past decade to integrate GEMs with enzyme information: mainly kinetic data, which tells 
us about the mechanics and operational rates of enzymes; but also proteomics data, which 
tells us about enzyme abundances. This chapter covers Paper IV, Paper V and Paper VI. 
Paper IV introduces a new method for integrating proteomics and kinetic data into GEMs 
and implements the approach in the consensus GEM of yeast. Paper V addresses the 
challenge of measuring proteomics data and proposes alternatives to increase the quality of 
said data. Finally, Paper VI uses the abovementioned method to analyze a large dataset of 
proteomics data to unveil previously unknown responses of yeast metabolism to stress. 
4.1. Enzyme constraints in metabolism 
Even though several computational approaches exist to connect metabolism to enzyme 
information, none of them allow for a genome-scale direct integration of a single proteomics 
dataset to create a condition-specific model. In this section I go through Paper IV, where 
GECKO, a method for adding enzyme constraints to a GEM, was developed and 
implemented in the consensus GEM of yeast. By doing so, I show that the enhanced model 
can predict physiological behavior that would otherwise have to be enforced with additional 
ad-hoc constraints. Furthermore, the enhanced model now allows to integrate proteomics 
data in a straightforward way and get insight into enzyme usage across metabolism. 
4.1.1. Integrating metabolism and enzymes: Come together 
GEMs have been thoroughly used as tools for predicting biological behavior [61]. A 
challenge in this regard is that GEMs most often rely on predetermined uptake rates of 
nutrients, as they have no internal “capacity constraints” to limit their intracellular fluxes 
with most fluxes in the network being completely unconstrained (Figure 2). These capacity 
constraints would be especially useful when studying biological conditions with high energy 
demand, such as during fast growth or under stress, as the cell is forced to process high 
amounts of substrate under these conditions, creating limitations in metabolism. In the case 
of GEMs, if we do not enforce an uptake rate, simulations yield either unlimited growth or 
unlimited tolerance to the stress, respectively. This is not observed in biology, as all 
organisms exhibit a maximum specific growth rate, and a maximum stress tolerance level. 
GEMs would therefore benefit from including capacity constraints. 
4.1. Enzyme constraints in metabolism 
28 
Perhaps the most obvious capacity constraint is the limitation of enzyme levels, as enzymes 
catalyze most of the reactions occurring inside the cell. When an enzyme catalyzes a 
reaction, it momentarily binds to the corresponding substrate(s), which forces a 
conformational change that leads to the substrate(s) being transformed into the product(s), 
after which the enzyme releases the product(s) and is free to operate again. The time that it 
takes for the enzyme to complete a full catalysis cycle, together with the amount of enzyme 
available, imposes a constraint on every reaction catalyzed by an enzyme. In other words, 
the reaction’s flux [mmol/gDWh] cannot exceed the enzyme’s specific catalytic rate, often 
referred to as the turnover number or kcat value [1/h], multiplied by the enzyme’s intracellular 
concentration [mmol/gDW]. 
The previously mentioned limitation on metabolic reactions is valid for the case in which a 
single enzyme catalyzes a single reaction (Figure 13A); however, other cases are extremely 
common in the cell [100]. Some enzymes exhibit metabolic activity towards several different 
substrates (and hence reactions); they are therefore known as promiscuous enzymes (Figure 
13B). It is also common to find several separate protein subunits that together form one 
catalytic unit, the latter known as an enzyme complex (Figure 13C). Finally, some reactions 
can be catalyzed by several different enzymes, which are referred to as isozymes (Figure 
13D). Therefore, we need to take these complex relationships into account if we want to 
integrate enzyme information into GEMs. 
Figure 13: The different relationships between enzymes and metabolic reactions. (A) Only one enzyme 
catalyzes only one reaction. (B) A promiscuous enzyme catalyzing two different reactions. (C) An enzyme 
complex catalyzing a reaction. (D) Two isozymes that can each separately catalyze the same reaction. 
Several genome-scale approaches have been developed to integrate the enzymatic and 
metabolic layers. One of the most popular approaches has been flux balance analysis with 
molecular crowding [19], which takes the idea of a limitation on enzymes’ activities, and 
sums them all to impose a single global constraint on the volume that proteins take up inside 
the cell. This approach has been modified to instead constrain the mass fraction inside the 
cell [101], and has been implemented in E. coli [19,100,102], yeast [103,104] and cancerous 
human cells [101,105]. A main feature of this approach is that it does not rely on proteomics 
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data, but instead the model computes the amounts of each protein that the cell requires. This 
can however be a disadvantage if there are in vivo limitations for some specific pathways 
that do not come close to the optimal in silico usage distribution. 
 
Some other approaches for combining metabolism with enzymes have also been developed, 
including modeling of RNA and protein synthesis processes starting from the transcription 
rates of genes [106,107], using proteomics datasets to infer hard constraints on fluxes [108], 
and even modeling most of the known processes in cell [109]. However, these approaches 
rely either on detailed biochemical knowledge of processes not fully understood in eukaryal 
cells, copious amounts of experimental data, and/or an excessive number of experimental 
parameters that are hard, or even impossible, to measure. Furthermore, something that none 
of these approaches allow for is directly integrating a single proteomics dataset on a genome-
scale way, with a flexible manner to account for missing data. 
 
 
4.1.2. GECKO: A simple tool for reducing complexity 
 
To address the aforementioned challenges, I present a method for enhancing Genome-scale 
modeling with Enzyme Constraints, using Kinetics and Omics (GECKO). GECKO adds 
pseudo-metabolites and pseudo-reactions to the model, i.e. additional rows and columns, 
respectively, to the stoichiometric matrix. The pseudo-metabolites correspond to enzymes, 
which will act as substrates in their corresponding reactions. Their stoichiometries are 
defined as inversely proportional to their kcat values (Figure 14A), to represent the fact that 
on a short timescale an enzyme has to be occupied momentarily and hence cannot be used 
twice at the same time. The pseudo-reactions in turn correspond to enzyme usages, i.e. the 
amount of enzyme occupied at a given moment by the corresponding metabolic task(s). This 
usage can be constrained with an upper bound equal to the measured abundance. With these 
additions, a mass balance for the enzymes yields the desired enzyme constraints we wanted 
to account for (Figure 14A). Note that this approach keeps the linear structure that 
characterizes GEMs, to in turn keep an efficient performance and compatibility with 
standard toolboxes [24,110]. 
 
 
 
 
Figure 14: The GECKO formalism accounts for enzyme constraints in GEMs. (A) GECKO adds for 
each enzymatic reaction in metabolism the corresponding enzyme as part of the stoichiometry of the reaction, 
and an enzyme usage pseudo-reaction limited with the measured abundance of said enzyme. (B) For any 
enzyme for which an abundance was detected, GECKO adds a corresponding enzyme usage pseudo-reaction. 
For each undetected enzyme, GECKO connects that enzyme to a shared enzyme pool and then adds a single 
enzyme usage pseudo-reaction to said pool. 
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Most proteomics methods, including mass spectrometry, are not specific enough to detect 
every single protein, and rely on protein extraction steps that might not be able to separate 
some proteins. Therefore, many enzymes present in the model might not have any measured 
abundance in the proteomics dataset whilst still being present in the cell. Therefore, the 
model needs to cope with incomplete data without forcing some abundances to zero just 
because they are undetected. This is achieved by introducing a pseudo-metabolite that pools 
together all undetected enzymes, constraining only the mass of said pool (Figure 14B), using 
average abundance values from the literature [111] and an average saturation factor [104]. 
This allows the method to be flexible enough to receive partial proteomics data or even no 
proteomics data; for the latter case all enzymes will be connected to the abovementioned 
pool, in a similar fashion to the molecular crowding approach [19].  
GECKO is designed to handle the previously introduced complex relationships between 
enzymes and reactions [112] (Figure 13). If an enzyme is promiscuous, the same enzyme 
usage will be shared by the different reactions it is associated to. If several subunits form an 
enzyme complex, then all subunits will be a part of the same reaction, and their 
stoichiometric coefficients will be adjusted by the corresponding subunit stoichiometry. If a 
reaction has several isozymes, then a separate reaction will be created for each isozyme, so 
that each isozyme can be used separately, and a so-called “arm” reaction will be created to 
keep the original upper bound of the reaction at the same value [113]. Finally, it is also 
relevant to note that the enzyme constraints described in this study only work for irreversible 
reactions (as in the opposite direction there would be production of enzyme). Therefore, 
GECKO splits reversible reactions in two separate irreversible reactions, adding the 
corresponding enzyme as substrate in both directions. 
The kinetic data used in GECKO is retrieved from literature in a semi-automatic manner. 
First, all kcat data from the BRENDA database [114] is downloaded, and for each reaction 
the best available kcat value is queried: preferring first a measurement of an enzyme from S. 
cerevisiae and for the same substrate from the reaction, but otherwise prioritizing a 
measurement from the same substrate, then from the same organism, and then from the same 
enzyme class. Whenever more than one kcat value is available, the highest one is chosen, to 
avoid over-constraining the model. After this automatic step, manual curation is performed 
based on previous data [104] and literature. Other enzyme information, such as gene-protein 
relationships and molecular weights of enzymes, is queried from additional databases, such 
as Swiss-Prot [115] and KEGG [116]. GECKO is publicly available at 
https://github.com/SysBioChalmers/GECKO and additional details can be found in Paper 
IV and its corresponding supplementary material. 
Compared to the previously presented modeling approaches (Section 4.1.1), GECKO stands 
out as the most straightforward way for quickly creating a model that can i) account for 
enzyme constraints based on semi-curated kinetic data and ii) integrate proteomics data. 
Compared to the different molecular crowding formalisms [19,100–105], GECKO is better 
equipped for working at the genome-scale by accounting for non-ideal enzyme/reaction 
relationships, and it can incorporate experimentally determined protein levels from 
proteomics. Compared to other genome-scale approaches [106–109], it does not require 
extensive knowledge on protein synthesis and/or numerous datasets, as it only depends on 
knowing which enzymes catalyze which reactions, and it can run with proteomics data from 
a single experiment (or even with no proteomics data). 
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4.1.3. Improvement of the yeast model with the addition of enzyme constraints 
By implementing GECKO on the yeast consensus GEM presented in Section 2.1, I created 
the enzyme-constrained model of yeast (hereafter referred to as ecYeast), which includes 
over 750 enzymes and over 3,200 reactions with enzyme constraints. The larger number of 
reactions is primarily because most enzymatic reactions are reversible, i.e. the method will 
split them in two reactions (see Section 4.1.2), and because over 300 enzymes exhibit 
promiscuity. Regarding kcat values, 52% of the values came from S. cerevisiae, 31% matched 
the specific substrate, and 44% were of the same enzyme class. This coverage varied widely 
across metabolic pathways, with some pathways having no measurements available for yeast 
(Figure 15). Comparing ecYeast to the original GEM, both models exhibited similar 
topology and similar simulation running times on a standard growth maximization FBA 
problem using the COBRA toolbox [24]. However, they are widely different in terms of 
simulation capabilities, as I will summarize below. 
Figure 15: Coverage in ecYeast of kcat values retrieved from the BRENDA database. Percentages are 
color coded depending on if the value came from measurements in S. cerevisiae and/or the exact substrate in 
the model. Pathways are color coded depending on the group of subsystems they belong to [117]. The 
number of enzymes in each pathway is shown in between brackets. 
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As previously stated, simulating maximization of biomass with a GEM relies on first 
defining a substrate uptake rate, as GEMs do not have any internal constraints to limit the 
amount of substrate that can be consumed. However, by accounting for enzyme constraints, 
there is now no need for pre-defining uptake rates. This was tested in simulations of ecYeast 
with no proteomics data, where it was observed that under several carbon sources for both 
minimal and complex media [118,119], this model came close to the measured maximum 
specific growth rates in aerobic batch cultivations (Figure 16A, average relative error of 
8%) without needing to limit any substrate uptake rate. In turn, the original GEM would 
predict infinite growth for all conditions, and even if we would fix the uptake rates, 
predictions would still be overestimated (Figure 4A in Paper IV). 
 
 
 
 
Figure 16: Implementation of GECKO in the consensus genome-scale model of yeast. (A) Maximum 
specific growth rate [h-1] predictions of ecYeast versus experimental values from batch growth. (B) Exchange 
rates [mmol/gDWh] predictions of ecYeast versus experimental values from chemostat cultivations. (C) 
Summed pathway usage [mg/gDW] in ecYeast at increasing levels of growth. (D) Cumulative distribution of 
the variability span of all fluxes in the network, for the original yeast GEM and the ecYeast model 
constrained with proteomics data. 
 
 
With ecYeast we can not only predict maximum specific growth rate, but also metabolic 
switches as a response of increased energy demand. S. cerevisiae is known to change its 
metabolic strategy for energy generation if it increases its growth rate over a certain threshold 
(the critical growth rate): from full respiration, the most energy efficient pathway in 
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metabolism, it switches to a mix of respiration and fermentation, the latter which produces 
ethanol. This phenomenon is known as the Crabtree effect [120] and is analogous to similar 
processes in E. coli [103] and cancerous cells [105]. There are numerous theories about what 
exactly drives this shift [121,122]; among them, protein allocation has been proposed as a 
possible explanation [103,104]. 
 
According to this theory, the switch occurs because even though respiration, and more 
specifically the oxidative phosphorylation pathway, is more efficient in terms of carbon, i.e. 
it has the highest ATP/carbon molar yield, it consists of enzymes that are large and not very 
fast, i.e. needs a large amount of protein to operate at higher rates. Fermentation is much 
more efficient in this regard, as it consists of smaller and faster enzymes, even though it 
yields less ATP per mole of carbon. As after the critical growth rate the cell enters a region 
referred to as the Janusian region [123] where it becomes both glucose-limited and protein-
limited, a new strategy is needed to achieve high rates of ATP production: a progressive 
trade-off between respiration and fermentation. 
 
I tested this theory in ecYeast (with no proteomics data), as this model accounts for the 
efficiencies of each enzyme, represented by their maximum specific rates. It is observed that 
the switch is indeed predicted (Figure 16B) following chemostat experimental data [124], 
whereas a regular GEM under the same conditions would instead show a linear increase in 
respiration with no metabolic switch, unless direct constraints on the exchange reactions 
would be used [125]. The metabolic switch can be further investigated through the total 
pathway usage, i.e. the sum of all enzyme usages in each specific pathway (Figure 16C): 
For anabolic pathways such as the terpenoid backbone biosynthesis (required for ergosterol 
production), there is no change in the enzyme usage slope after the critical growth rate, 
whereas there is a consistent decrease of both oxidative phosphorylation and the 
tricarboxylic acid (TCA) cycle, the latter needed for creating enough redox potential to 
enable respiration. In turn, the slope of glycolysis, and correspondingly fermentation, 
significantly increases, supporting the idea that fermentation gradually replaces respiration 
at high growth rates. 
 
As a final study GECKO was tested as a way of reducing flux variability. Flux variability 
refers to the fact that, given the undetermined nature of GEMs, even though a specific 
solution is obtained when simulating the model with e.g. FBA, this solution is often non-
unique (Figure 3), and many more solutions are equally optimal. In general, we wish to 
reduce this variability in our model predictions, as many of the possible solutions are not 
biologically meaningful. I tested whether flux variability could be reduced by performing 
FVA [28] under the reference conditions from the stress dataset (Paper II), on both the 
original model and the ecYeast model constrained with the proteomics data from the 
corresponding condition. Although the simulated exchange fluxes were similar on both 
models, the analysis showed that 64% of fluxes in the metabolic model reduced their 
variability after adding enzyme constraints, and overall the variability distributions were 
significantly different (Figure 16D). In particular, only 1.5% of the fluxes in ecYeast had 
maximum variability, compared to 25% of the fluxes in the original metabolic model. 
GECKO therefore proves to be a useful tool for decreasing variability of model predictions, 
while maintaining a physiologically relevant solution. 
 
In conclusion, by implementing GECKO the enhanced model i) can predict maximum 
specific growth rates without needing to set any uptake rates, ii) prefers fermentation as an 
efficiency strategy at high growth rates, iii) allows studying enzyme/pathway usage at the 
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genome-scale, and iv) has reduced flux variability. The enzyme-constrained model of yeast 
is available at https://github.com/SysBioChalmers/ecModels. 
 
Before moving on to the next section, it is important to address the fact that simulations of 
ecYeast rely to a large extent on the choice of kcat values. For example, when predicting 
maximum specific growth rates under different carbon sources (Figure 16A), I assessed 
10,000 simulations of the model but with random kcat values based on a gamma distribution 
fitted to the kcat data in the model. I saw that less than 10 of the simulations had a prediction 
error of 8% or less, whereas most models fitted the data poorly. I saw the same phenomenon 
when predicting chemostat growth (Figure 16B): from 10,000 simulations with randomized 
kcat values, over 99.9% showed the metabolic shift towards fermentation at a specific growth 
rate under 0.1 h-1 or no fermentation at all (Figure S8 in Paper IV). These findings indicate 
that it is important to perform manual curation to the kinetic data (at least in the energy-
generating pathways), as incorrect values from databases could introduce bias in our 
simulations. 
 
 
4.2. The challenge of using absolute proteomics data 
 
Now that I have introduced a proteomics dataset under multiple levels of stress (Paper II) 
and a method for integrating proteomics data (Paper IV), the final challenge is to apply the 
method on the dataset in order to study enzyme usage across experimental conditions. 
However, before proceeding it is relevant to address the variability of proteomics data, and 
the challenges that this imposes on our analysis, as on a first glance the proteomics data 
clusters depending on the measuring instrument rather than the phenotypic response of yeast 
(Figure 9F). In this section I go through Paper V, where a dataset of yeast grown at 
reference conditions in chemostat was generated to study the variability of the iBAQ 
technique for estimating protein abundances. Furthermore, alternative approaches for 
converting the MS intensities into protein abundances are assessed to find which one 
increases accuracy and precision of predictions. 
 
 
4.2.1. Variability in proteomics: Golden slumbers 
 
To study variability of proteomics data computed using the iBAQ approach, a proteomics 
dataset was generated with both biological replicates, i.e. samples from different cultivations 
grown under the same conditions and analyzed by the MS instrument at the same time; and 
different MS batches, i.e. samples from the same cultivation analyzed at different times in 
the MS instrument. S. cerevisiae, strain CEN.PK113-7D, was grown in triplicate in aerobic 
glucose-limited chemostats in minimal media at a dilution rate of 0.1 h-1, and each cultivation 
was later analyzed on three separate runs of the MS instrument, with a time difference of 12 
and 30 days. The previously introduced iBAQ approach [80] was used to estimate absolute 
abundances of an internal standard from known abundances of an external standard, and the 
SILAC approach [81] was used to infer the absolute abundances for all samples from the 
internal standard intensities. All experimental settings were kept the same as described in 
Paper II. 
 
As all measurements in this dataset come from the same experimental conditions, for each 
protein the values across measurements should be the same. I tested whether this was true 
by separately comparing the biological replicates (Figure 17A) and the MS batches (Figure 
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17B). Overall, there is a good agreement across biological replicates, similar to what has 
been observed in previous studies [126]; however, batches analyzed at different time points 
exhibit a much larger variability between them, a phenomenon referred to as the “batch 
effect” that is observed in many types of omics data [127]. This is confirmed when 
performing a PCA on the data (Figure 17C), where samples cluster based on the MS batches. 
This is undesired, as ideally the larger source of variability should come from the biology 
and not from the measuring instrument. 
 
 
 
 
Figure 17: Variability of the proteomics data when using the iBAQ technique. (A-B) Variability between 
biological replicates (A) and batches (B). Blue circles correspond to fold changes between replicates lower 
than 2-fold, yellow between 2-fold and 10-fold, and grey above 10-fold. The coefficient of determination 
(R2) and the median absolute fold change (FCm) are shown. (C) PCA of all samples, indicating the amount of 
variability explained by each of the components. Different batches are shown with different colors, and 
different biological replicates with different shapes. (D) Known abundances of the external standard versus 
detected MS intensities. A linear fit to the data and a linear model based on scaling the data are shown. (E) 
Total detected protein for each of the 6 internal standards. (F) Total detected protein for each of the 18 
samples. The colors match the corresponding internal standard used to compute the abundances.  
 
 
A big influence on the batch variability might be the use of an external standard, as the 
detection of the proteins in the external standard carries a large degree of variability. Even 
though the UPS2 mix has only six levels of molar abundance, the detection by the MS 
instrument spans up to an order of magnitude of variability for each of the four detected 
levels (Figure 17D), in accordance to previous studies that use the iBAQ approach [80,128]. 
Note that as this data is used for building the standard curve in the log space, many curves 
can fit the data almost as well (e.g., both curves shown in Figure 17D). However, even a 
small change of slope can have a big influence on the final absolute values; in fact, using the 
optimal linear fit for each of the 6 external standard measurements leads to quite different 
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results for both internal standards (Figure 17E) and samples (Figure 17F) when we add up 
all predicted abundances. As in all cases the same amount of protein was injected into the 
MS instrument, we should expect the same amount to be detected. Therefore, I proceeded to 
test if the variability can be reduced by trying different approaches for rescaling the data so 
that it adds up to the same injected protein mass. 
 
 
4.2.2. Increasing the quality of proteomics data: Little by little 
 
In total I implemented three rescaling methods and compared them to the traditional iBAQ 
approach, referred to in the following as method 1. Method 2 rescaled the abundance values 
computed from method 1 so that the sum of all protein abundances would add up to the total 
injected protein mass. Method 3 is known as the total protein approach (TPA) [129] and is 
similar to method 2, but instead of using the abundances from method 1, it directly uses the 
detected MS intensities. Finally, method 4 is a variation of the TPA approach that first 
normalizes the MS intensities by the corresponding number of theoretical peptides that each 
protein has [130]. Note that methods 3 and 4 bypass the need of an external standard entirely. 
The full formalism for each method is available in Paper V. 
 
In order to compare the performance of these methods, two important metrics that should be 
introduced here are accuracy and precision, as they are both routinely used in proteomics 
[131]. Accuracy refers to how far off the true value the prediction lies, i.e. if a prediction is 
consistently different than the expected value we can say the prediction is not accurate (or 
biased). Precision on the other hand refers to how variable said prediction is when the same 
measurement is repeated, i.e. if a measurement tends to take many different values, even if 
it is on average close to the expected value, we can say the prediction is imprecise (or non-
reproducible). Note that a measurement can be inaccurate, imprecise, or both (Figure 18). 
In the following, I will look into accuracy and precision of each of the 4 mentioned methods. 
 
 
 
 
Figure 18: Exemplifying the concepts of accuracy and precision. (A) A measurement that is both accurate 
and precise. (B) A measurement that although precise is inaccurate. (C) A measurement that is on average 
accurate but imprecise. (D) A measurement that is neither accurate nor precise. 
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Accuracy was studied with two main metrics: UPS2 prediction error and ribosomal 
stoichiometry prediction error. For the first metric, the predicted abundances for the detected 
proteins in the external standard were compared to the known values in the UPS2 mix. This 
yielded similar performance for methods 1, 2 and 4, whereas method 3 performed 
significantly worse (Figure 19A). For the second metric, I looked into the stoichiometry of 
ribosomal proteins, which are known to be expressed in a 1-1 molar ratio [132]; therefore, 
comparing all molar estimates to the median value can be a good metric of accuracy [133]. 
It can again be observed that methods 1, 2 and 4 perform similarly, while method 3 has a 
lower performance (Figure 19B). 
Figure 19: Accuracy and precision in a proteomics dataset after varying the scaling method. A fold 
change of 2 is indicated with a vertical segmented line. (A) Accuracy of predicting the external standard 
abundances (167 measurements). (B) Accuracy of predicting the ribosomal protein abundances (731 
measurements). (C) Precision of predicting the data across batches (21,320 measurements). 
Finally, precision was studied by performing the same comparison as in Figure 17B for all 
4 methods. This comparison yielded that methods 3 and 4 perform better than methods 1 and 
2 (Figure 19C). In particular, the original iBAQ method has around 40% of its protein 
estimates with a variability over a 2-fold within batches, whereas this drops to 20% in the 
case of the two methods that skip the external standard (methods 3 and 4). Considering all 
of the above, method 4 stands out as the best performing method for estimating protein 
abundances, as it is more accurate than method 3 and more precise than methods 1 and 2. 
Note that even though the external standard data was not used in this method, the linear 
models that convert the intensity data into absolute abundances are quite similar (Figure 
17D). 
It is important to mention that even though method 4 proved to be the best performing 
method, it is by no means a perfect method, with batch variability still being considerably 
larger than biological variability (Figure 2 in Paper V). This clearly shows the limitations 
of working with absolute proteomics data, and that this variability should be accounted for 
when applying methods (e.g. GECKO) that use this type of data. In the next section I will 
proceed with an analysis on proteomics data and assess the effect of filtering out the fraction 
of the data that exhibits high variability. The data, together with the computational analysis 
in this section, are available at https://github.com/SysBioChalmers/reproduce.  
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4.3. Enzyme usage of S. cerevisiae during stress 
 
Being aware of the inherent variability of the absolute proteomics data used, we proceed to 
the final part of this chapter, where I go through Paper VI. Here, enzyme-constrained 
models with proteomics data were generated for each of the experimental conditions from 
Paper II, filtering out the data that was excessively variable. The models had improved 
predicting performance compared to alternative approaches and allowed studying enzyme 
usage both at the global and stress-specific levels. 
 
 
4.3.1. Condition-specific models of yeast at increasing levels of stress 
 
For each experimental condition from the stress dataset, a condition-specific model was 
created using GECKO and the measured proteomics data. The data was first filtered to avoid 
the introduction of a bias in our analysis, leaving out any protein that had an average fold 
change over 2 between the reference conditions of the two datasets. The reasoning behind 
this is that if a value fluctuates in several folds between measurements of the same biological 
condition, it should not be trusted. This left 1746 proteins from the original 2318 measured 
proteins. Additionally, measurements from the subunits in the oxidative phosphorylation 
complexes were rescaled to be proportional to their median values. 
 
For all enzymes in the model that had a direct match in the filtered proteomics data, an upper 
bound was set based on the average value and standard deviation across triplicates. 
Depending on the condition, this was possible for between 254 and 340 enzymes. Note that 
for each condition, around 7 measurements were increased in an iterative fashion to allow 
functional models, and the corresponding proteins were hence not accounted for in any 
further analysis. Finally, for all unmeasured enzymes in the model, the shared pool 
assumption was used (Figure 14B) assuming an average saturation factor of 50%. 
Considering both individual enzyme constraints and the shared enzyme pool, the condition-
specific models accounted on average for 0.33 g/gDW of protein, i.e. 57.5% of the total 
protein content. 
 
The created condition-specific models were simulated using pFBA and minimizing the 
carbon uptake [g/gDWh] subject to a growth of 0.1 h-1 (the dilution rate of all chemostats). 
Also, for each condition the NGAM value was increased so that the exchange rates of 
glucose, oxygen, CO2 and ethanol would fit the measured values, as it has been shown that 
the stress response of yeast is tightly associated to an increase in energy maintenance [82]. 
These simulations were compared to corresponding simulations of the original metabolic 
model and an enzyme-constrained model built with no proteomics data (using the shared 
pool formalism presented in Section 4.1.2). Overall, the condition-specific models showed 
the best performance amongst all three approaches (Figure 20A). 
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Figure 20: Condition-specific models. (A) Average error when predicting physiological data (glucose, O2, 
CO2 and ethanol exchange rates) with the original GEM of yeast, ecYeast without proteomics data, and 
ecYeast with proteomics data. (B) Enzyme usage of the complexes in oxidative phosphorylation at osmotic 
stress conditions of 1.2 M of NaCl. A diagram of oxidative phosphorylation is shown for reference. 
 
 
As already covered in Section 4.1.3, a purely metabolic model is not able to choose 
fermentation as an energy-generating pathway, therefore the metabolic model fails to predict 
ethanol at high temperature (Figure 9A) or osmotic levels (Figure 9B). Due to the same 
reason, the metabolic model predicts only consumption of ethanol for conditions of ethanol 
stress, where there should be a mixed consumption of glucose and ethanol (Figure 9C). This 
is because consuming ethanol yields the highest ATP/carbon yield, even though it relies 
solely on respiration. In turn, the condition-specific enzyme-constrained models do capture 
all these mentioned phenomena. 
 
Comparing to the enzyme-constrained models with no proteomics data, overall predictions 
are also better when incorporating condition-specific proteomics data (Figure 20A). This is 
because some of the metabolic responses of yeast to stress are not due to a limitation in the 
total protein content, but due to limitations of some specific protein abundances. For 
instance, at high levels of osmotic stress, oxidative phosphorylation complexes are not 
highly abundant, causing a saturation of respiration that forces fermentation (Figure 20B) 
without increasing the glucose uptake, something that would not be possible to predict with 
the molecular crowding formalism. 
 
 
4.3.2. Enzyme usage response of yeast under stress 
 
With the condition-specific models it is now possible to study enzyme usage at the genome-
scale, both in absolute terms or as percentages of the measured values. It can be seen that 
some enzymes have a usage close to 100%; however, most enzymes tend to have usage 
values far below the measured abundances (Figure 21A). As this could be an effect of the 
kcat values assigned (given that GECKO prefers data from more efficient enzymes), I 
examined any enzyme that showed a positive correlation of their enzyme usage with their 
own abundance (R2 > 0.9) across all experimental conditions, pointing to a constant 
percentual enzyme usage. In total, 35 enzymes were in this group (Table S2 in Paper VI), 
with an overrepresentation of oxidative phosphorylation proteins. The fact that these 35 
enzymes show a constant percentual enzyme usage implies that the cell tightly regulates the 
expression of those enzymes, i.e. they are important for cell growth and could be either 
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translationally or transcriptionally controlled. The latter has been experimentally shown for 
some of these enzymes [134] but remains to be confirmed for most of them. 
Figure 21: Enzyme usage trends. (A) Enzyme usage versus concentration for all enzymes in yeast, color 
coded by the type of stress. The obscured area refers to a region of infeasibility, as usage must remain below 
the abundance. A linear fit to all data is shown with a straight line. (B) PCA of percentual enzyme usages. 
Colors represent the stress types and marker sizes represent the stress level. The amount of variability that 
each component represents is indicated. (C) Enzymes showing either an increase (left side) or decrease (right 
side) in usage as the level of a specific type of stress increases, ranked by the slope of the fitted linear model. 
The maximum enzyme usage observed is shown on top of each bar. 
Enzyme usage can also be studied among stress levels. It is less biased by the “batch effect” 
previously observed (Figure 21B), as it considers both the protein abundances and the 
metabolic flux. Additionally, it is a useful layer of information that connects proteomics with 
fluxomics, capturing metabolic responses that proteomics do not, while staying within the 
enzyme level. This is exemplified by the fact that it displays a clear convergent trend towards 
the reference condition for the ethanol stress chemostats (Figure 21B), a behavior that is not 
observed in the proteomics data (Figure 9F), but it is observed in the flux predictions, as an 
increased concentration of ethanol in the media pushes yeast towards increased glucose 
consumption (Figure 9C). 
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Finally, enzyme usage can also be studied within stress types. For this, I looked for enzymes 
that show a positive or negative correlation of their percentual usage with the stress level (R2 
> 0.9). These enzymes are expected to be important for stress tolerance: for instance, if an
enzyme shows a positive correlation, it means that either the metabolic flux is systematically
increasing, and/or the enzyme abundance is systematically decreasing. Either way, it points
to an enzyme that plays a more important role as the stress increases, and could be a good
target for studies to improve tolerance to said stress. The analysis revealed several enzymes
that increased or decreased consistently with the stress levels (Figure 21C). From them,
some were consistent with previous experimental studies that showed that engineering the
same pathway could increase stress tolerance, such as ergosterol biosynthesis during heat
stress [135]. However, most of them remain to be tested to assess if modified expression of
the corresponding genes could yield a more tolerant strain to the corresponding stress.
In conclusion, using GECKO to constrain GEM simulations with proteomics data allows to 
study enzyme usage at the genome-scale, to find previously unknown trends in enzyme 
usage, both at the global level and at increasing levels of stress. The computational analysis 
in this section is available at https://github.com/SysBioChalmers/ecModels. 

43 
5. Conclusion
In this thesis, I have explored different approaches for combining genome-scale modeling 
with experimental omics data. I started by reviewing the metabolic modeling field and how 
it has been applied in S. cerevisiae (Paper I), to show that two challenges in the field are to 
properly evaluate the quality of GEMs and consistent omics data integration. I then 
proceeded to establish foundation stones for high quality GEMs and omics data. For the 
former, I introduced a version control strategy that records development of the model in a 
sustainable way (Section 2.1) and implemented it for the consensus GEM of yeast. For the 
latter, I introduced a multi-omics dataset of yeast grown under several conditions of stress 
(Paper II), showing that yeast re-arranges its metabolic distribution, biomass composition 
and protein levels in a drastic way as the level of stress increases. 
Most of the thesis dealt with integration of lipid data and enzyme data into GEMs. To 
integrate lipid data, I have introduced SLIMEr (Paper III). By implementing SLIMEr on 
yeast, I showed that I could accurately represent amounts of lipid species, analyze the 
flexibility of the resulting distribution, and compute energy costs of moving from one 
metabolic state to another. To integrate enzyme data in GEMs, I have introduced GECKO 
(Paper IV). By implementing GECKO on yeast, I showed that the new model could 
correctly describe yeast physiology at high growth rates, which are conditions that entail 
high enzymatic demand, and compute usage among enzymes and metabolic pathways. 
GECKO also allows to directly integrate quantitative proteomics data; by doing so flux 
variability of the model was significantly reduced.  
I also assessed the quality of the protein quantification technique employed throughout this 
thesis (Paper V). I presented current limitations of this technique, such as batch variability 
being higher than biological variability. Moreover, I introduced a simple normalization and 
rescaling approach that performs as accurately yet more precisely than methods that rely on 
external standards. Finally, I used GECKO to integrate the proteomics data from the stress 
dataset (Paper VI). I showed that the generated condition-specific models could better 
predict the metabolic stress response compared to previous modeling approaches. 
Furthermore, the model gave insight into the genome-wide distribution of usage both at the 
global and stress-specific levels, finding enzymes that play key-roles in different pathways 
inside the cell at conditions of high energy demand. 
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6. Future perspectives
While systems biology has become a well-established field, it also remains emergent in 
many ways: new experimental methods yield new types of omics data and insight; as 
computational biologists we then need to continuously update the way we analyze data and 
interpret simulation results. In this section I provide some views on where I think the field 
is moving to, with respect to the themes covered by this thesis. 
6.1. Reproducible software in biology: Modeling with advantage 
Reproducibility is a foundation stone from which all research should be built upon [62]. In 
the case of computational modeling, version control tools like Git and hosting services like 
GitHub are essential for achieving both traceability and reproducibility. Computational 
biology has been slow to adopt these good software development practices, but since a few 
years this has been changing, with more groups realizing the value of version control for 
reproducible research [127,136]. Version control is not only helpful when collaborating, but 
also when working alone, as we are always collaborating with our future self. On several 
occasions throughout my PhD I had to re-run analysis that I had done a few months before, 
and my experience was always better when the code was version-controlled, as I would be 
confident that no undesired changes had been introduced. 
All the computational tools presented in this thesis are available in GitHub, so that most of 
the performed analysis can be replicated by any user. This sustainable approach to code 
development does however come with some minor challenges: it can become hard to 
maintain, as software packages and toolboxes are often being updated, which means that we 
need to adapt our code appropriately to maintain its proper functioning, or use additional 
tools such as dependency tracking and/or container platforms. Despite these hurdles, I 
envision that with proper investment and support, version control will become not just a 
standard, but a requirement for anyone performing computational analysis. Particularly, I 
also hope the practice of keeping track of GEMs with version control will spread to become 
a required feature by the community. 
Moving forward in the sustainable development of GEMs, I believe that the idea of 
standardized testing of models needs to be implemented at a larger scale. In this regard, a 
recently developed tool for metabolic model testing (Paper VIII) is starting to be used by 
GEMs as an automatic tool for testing model quality, fully compatible with the version 
control strategy outlined in Section 2.1, acting as an additional test when changes are 
requested to be integrated in the model. I then hope this tool becomes the main metric to 
measure GEM quality, and a tool to lead development teams that curate these models. 
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6.2. Lipid constraints: Growing strong 
The addition of SLIME reactions to a GEM opens many new paths for testing the flexibility 
of lipid metabolism in a quantitative way. As lipid quantification becomes cheaper and easier 
to parallelize, a natural extension of SLIMEr would be to further constrain the lipid 
distribution, this time with the acyl chain distribution for each lipid class. This would be 
especially relevant for metabolic engineering projects focused on reorganizing the acyl chain 
configuration within specific lipid classes [137]. It might as well be of value to include more 
lipid species in yeast-GEM, considering that only 80% mass-wise of the lipid content is 
currently covered, and only C16, C18, C24 and C26 acyl chains are present in the model.  
It is also of interest to study the benefit of this approach for other organisms, especially in 
other yeast species that display a much higher lipid content, such as Yarrowia lipolytica [6]. 
In fact, SLIMEr has recently been implemented in Rhodotorula toruloides [138]. A 
challenge to implement the approach in even more organisms is the non-standardized way 
that lipid names are often annotated in GEMs, as this requires intensive manual work for 
properly creating the generic pseudo-metabolites (backbones and acyl chains) and adding 
the SLIME reactions. Efforts in including standardized IDs in GEMs [34] are fundamental 
for making this step as seamless as possible. 
6.3. Enzyme constraints: From soft to hard and back 
Enhancing a GEM with enzyme constraints has shown improved prediction capabilities, and 
I think this approach can be developed even further. So far, I have presented two variations 
of the approach: a first one in which no proteomics data is used and only a single constraint 
is applied, and a second one in which proteomics data is used as constraints in single 
enzymes. I have defined these as “soft” and “hard” approaches, respectively (Section 1.3.4). 
Note that the latter approach requires a couple of flexibilization steps in the proteomics data 
(Paper VI), which decreases the coverage of the method, as the flexibilized enzymes are 
removed from posterior analysis. This method could then be adapted to avoid excessive 
flexibilization, by for instance creating constraints for subgroups of enzymes, e.g. pathways, 
instead of single enzymes. Alternatively, the soft approach could be further used by 
comparing enzyme usage predictions to the measured abundances. 
Finally, note that in both soft and hard approaches there is a constraint on the shared 
metabolite pool of all unmeasured enzymes (Section 4.1.2), which can affect simulations 
considerably (Section 4.1.3). I envision an even “softer” approach, in which no actual 
constraint is imposed (not even on the shared metabolite pool), and instead the model is run 
to compute enzyme usages, to compare them later to proteomics data. All these approaches 
could offer new insight and I believe should be assessed in a future study. 
6.4. The importance of good data: House of cards 
Thanks to its ease of use, GECKO has already been used in a genome-scale model of B. 
subtilis [139] and even more models are currently being developed for bacteria, other yeasts 
and even human cell lines (Paper XII). However, something that has become clear after the 
analysis in this thesis is that the developed approach depends to a large extent on the different 
types of data used: the kinetic data obtained from literature, the measured proteomics data, 
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the biochemical knowledge used to build the original metabolic network, and the biomass 
composition used in simulations. In the following I address the limitations that this imposes 
for moving forward with GECKO and how these limitations could be addressed in future 
studies. 
Regarding kinetic data, I have previously mentioned that simulations can majorly be affected 
by the choice of kcat values, and that even for the model organism S. cerevisiae the available 
kinetic data in the literature is scarce (Figure 15), which means that for other less studied 
organisms the scarcity will be even higher. Hence, studies that could generate kinetic 
information at the genome-scale in a systematic way would be of the upmost usefulness to 
the modeling community [140]. This however presents a set of challenges of its own, as the 
experimental setup for measuring kinetic parameters in a high-throughput way is non-trivial, 
and values vary among organisms and experimental conditions. Furthermore, enzymes 
inside the cell are subject to evolutionary pressure, which over time could affect some of 
their kinetic parameters, rendering the original measurements outdated. The latter however 
might be more prevalent in pathways that the cell does not routinely use (e.g. resistance to 
toxic compounds) and might not be a huge deterrent in our analysis. 
Regarding proteomics, in this thesis I have outlined the challenges this type of omics data 
presents when it comes to reproducibility across measurements (Paper V). These challenges 
have also become evident in a recent study [141] that integrated different datasets of MS-
generated proteomics measurements, which yielded large variability across studies. To cope 
with these challenges, in this thesis I explored different scaling methods (Paper V) and 
filtered out excessively variable data (Paper VI) before applying any quantitative analysis. 
However, it could very well be the case that unreliable data is still included in our analysis. 
New methods for measuring absolute proteomics abundance that exhibit improved precision 
[142] should become the de-facto way of generating data, and additional control quality
checks should be put in place to guarantee the robustness of the data used.
Regarding biochemical knowledge, it is important to consider that GEMs are built based on 
our current knowledge of the roles of different genes, and the activities of different enzymes. 
However, this knowledge remains incomplete, with a big fraction of experimentally detected 
metabolites not present in GEMs [143]. Additionally, due to this missing knowledge a big 
part of metabolic networks often contains blocked reactions. To address the latter, gap-filling 
techniques have been developed that can reduce the problem to some extent [144]. 
Nonetheless, further efforts towards a fully characterized network are still needed. 
A final way of improving predictions could be with a better-defined biomass composition. 
Using GECKO to infer enzyme usages predicted that many of the detected enzymes had zero 
usage for all conditions (Paper VI), which is unlikely to be a realistic biological behavior, 
i.e. the cell producing a big part of its metabolic proteome for no apparent reason. What is
more likely is that we have limited knowledge of the metabolic network, especially when it
comes to the biomass requirements: As many pathways in the metabolic network are for the
production of specific compounds that are currently not defined as part of the biomass
pseudo-reaction, it is very likely that if we would re-formulate the biomass pseudo-reaction
to account for more components, the pathways generating said components would become
unblocked and hence enzymes in those pathways would have non-zero usage. A better
characterization of the biomass composition would then yield more meaningful simulations
[57].
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6.5. Systems biology: Over the hills and far away 
What is the ultimate goal of systems biology? A straightforward (but perhaps naïve) answer 
is “to simulate the complete behavior of a cell”. However, I believe it is relevant to consider 
the aphorism “all models are wrong, but some are useful” [145]. A full depiction of the cell 
would be extremely hard to attain, and perhaps not significantly more useful than a simpler 
representation. Introduced in 2012, whole-cell modeling, i.e. modeling all processes in the 
cell with a  single model [109], seemed promising at the time; however, numerous limitations 
in terms of parameter estimation have prevented the field to advance in that direction [146]. 
Many of these parameters might not be possible to measure, or might even be changing due 
to evolutionary pressure, making the goal of a fully encompassing model an elusive 
objective. 
I believe a simpler approach in which we slowly build our understanding of the cell by 
integrating one layer of data at the time is a better way to move forward. Particularly, in this 
thesis I have introduced GECKO, which allows connecting two important levels of 
information in the cell (metabolism and enzymes), to then infer enzyme usage. Here, it is 
vital to note that many additional processes affect the metabolic rates in combination with 
the enzyme levels, such as the degree of saturation of the enzyme due to the substrate levels, 
the thermodynamics of the reaction, inhibitory/activation effects, and the influence of the 
environment [147]. In fact, my simulations show that enzyme usage seems to remain rather 
low for many enzymes in metabolism (Figure 21A), which has been observed 
experimentally for bacteria [148]. Therefore, this usage should be interpreted as a minimum 
enzyme usage, or what has also been referred to as “minimal enzyme demand” [149]. 
The next step of this approach would then be to account for more types of constraints, as 
evolution pushes biological systems to be multi-constrained by different intracellular 
abundances and processes. There are a plethora of studies assessing the benefits of different 
types of constraints on GEMs, such as substrate/product levels [149], gene expression rates 
[107], metabolite transport/diffusion [150] and Gibbs energy dissipation [122]. An 
integrative study that would assess the benefits of combining one or more of these 
approaches with GECKO would be in my opinion a logical next step. In particular, given 
that not all of the experimental data in this study was used for integration with GEMs (Paper 
II), accounting for transcriptomics data and protein degradation seems to be an attractive 
way of moving forward. 
And then what? As introduced in Chapter 1, metabolic engineering has recently benefitted 
from efficient techniques for fine-tuning the levels of gene expression [10]. I envision the 
modeling framework presented in this thesis as a tool for predicting the optimal levels of 
said expression: The GECKO approach already yields enzyme usage predictions, and by 
accounting for additional processes such as the mRNA/enzyme relationship [107] and the 
enzyme concentration/usage relationship [149], we would have a model that predicts the full 
effect of gene expression levels on metabolic fluxes. This model could guide 
experimentalists to decide which genes to target and what levels of over-expression / down-
regulation to use, for them to achieve the desired phenotypic traits of their mutant strains. 
Ultimately, I hope this thesis inspires an increased use of model-based design in metabolic 
engineering. 
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